Lupins Q1 PAT declined 58% YoY to Rs 3.58 bn (~28% below our estimate) due to pricing pressure in US, GST impact in India and appreciation of Rs/ USD. US sales declined 14% QoQ to USD 238 mn on increased pricing pressure in key products (like gGlumetza).